196 related articles for article (PubMed ID: 26046371)
1. A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy.
Luoni C; Canevini MP; Capovilla G; De Sarro G; Galimberti CA; Gatti G; Guerrini R; La Neve A; Mazzucchelli I; Rosati E; Specchio LM; Striano S; Tinuper P; Perucca E
Epilepsia; 2015 Jul; 56(7):1162-73. PubMed ID: 26046371
[TBL] [Abstract][Full Text] [Related]
2. Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments.
Luoni C; Bisulli F; Canevini MP; De Sarro G; Fattore C; Galimberti CA; Gatti G; La Neve A; Muscas G; Specchio LM; Striano S; Perucca E;
Epilepsia; 2011 Dec; 52(12):2181-91. PubMed ID: 22136077
[TBL] [Abstract][Full Text] [Related]
3. Direct cost of medical management of epilepsy among adults in Italy: a prospective cost-of-illness study (EPICOS).
Beghi E; Garattini L; Ricci E; Cornago D; Parazzini F;
Epilepsia; 2004 Feb; 45(2):171-8. PubMed ID: 14738425
[TBL] [Abstract][Full Text] [Related]
4. Direct medical cost of children and adolescents epilepsy at a university setting in Croatia.
Prpić I; Boban M; Skarpa-Prpić I; Jurjević A; Babić T; Fiket D
Coll Antropol; 2009 Jun; 33(2):503-8. PubMed ID: 19662770
[TBL] [Abstract][Full Text] [Related]
5. The costs of epilepsy in Italy: a prospective cost-of-illness study in referral patients with disease of different severity.
Tetto A; Manzoni P; Millul A; Beghi E; Garattini L; Tartara A; Avanzini G;
Epilepsy Res; 2002 Feb; 48(3):207-16. PubMed ID: 11904239
[TBL] [Abstract][Full Text] [Related]
6. Cost-of-illness of epilepsy in Italy. Data from a multicentre observational study (Episcreen).
Berto P; Tinuper P; Viaggi S
Pharmacoeconomics; 2000 Feb; 17(2):197-208. PubMed ID: 10947342
[TBL] [Abstract][Full Text] [Related]
7. Trends in resource utilization and prescription of anticonvulsants for patients with active epilepsy in Germany.
Strzelczyk A; Haag A; Reese JP; Nickolay T; Oertel WH; Dodel R; Knake S; Rosenow F; Hamer HM
Epilepsy Behav; 2013 Jun; 27(3):433-8. PubMed ID: 23591262
[TBL] [Abstract][Full Text] [Related]
8. Relationship between adverse effects of antiepileptic drugs, number of coprescribed drugs, and drug load in a large cohort of consecutive patients with drug-refractory epilepsy.
Canevini MP; De Sarro G; Galimberti CA; Gatti G; Licchetta L; Malerba A; Muscas G; La Neve A; Striano P; Perucca E;
Epilepsia; 2010 May; 51(5):797-804. PubMed ID: 20545754
[TBL] [Abstract][Full Text] [Related]
9. Medical care costs of newly diagnosed children with structural-metabolic epilepsy: a one year prevalence-based approached.
Salih MR; Bahari MB; Shafie AA; Hassali MA; Al-lela OQ; Abd AY; Ganesan VM
Seizure; 2012 Dec; 21(10):764-9. PubMed ID: 22939458
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centers in Italy.
Alexandre V; Capovilla G; Fattore C; Franco V; Gambardella A; Guerrini R; La Briola F; Ladogana M; Rosati E; Specchio LM; Striano S; Perucca E;
Epilepsia; 2010 May; 51(5):921-5. PubMed ID: 20132292
[TBL] [Abstract][Full Text] [Related]
11. Healthcare utilization and costs in adults with stable and uncontrolled epilepsy.
Cramer JA; Wang ZJ; Chang E; Powers A; Copher R; Cherepanov D; Broder MS
Epilepsy Behav; 2014 Feb; 31():356-62. PubMed ID: 24239435
[TBL] [Abstract][Full Text] [Related]
12. Direct and indirect costs of refractory epilepsy in a tertiary epilepsy center in Germany.
Hamer HM; Spottke A; Aletsee C; Knake S; Reis J; Strzelczyk A; Oertel WH; Rosenow F; Dodel R
Epilepsia; 2006 Dec; 47(12):2165-72. PubMed ID: 17201718
[TBL] [Abstract][Full Text] [Related]
13. [Cost-effectiveness of epilepsy surgery in a cohort of patients with medically intractable partial epilepsy--preliminary results].
Picot MC; Neveu D; Kahane P; Crespel A; Gélisse P; Hirsch E; Derambure P; Dupont S; Landré E; Chassoux F; Valton L; Vignal JP; Marchal C; Rougier A; Lamy C; Semah F; Biraben A; Arzimanoglou A; Petit J; Thomas P; Dujols P; Ryvlin P
Rev Neurol (Paris); 2004 Jun; 160 Spec No 1():5S354-67. PubMed ID: 15331984
[TBL] [Abstract][Full Text] [Related]
14. Resource utilization and direct costs of pediatric HIV in Italy.
Giacomet V; Fabiano V; Lo Muto R; Caiazzo MA; Curto A; Rampon O; Zuccotti GV; Garattini L
AIDS Care; 2013; 25(11):1392-8. PubMed ID: 23414422
[TBL] [Abstract][Full Text] [Related]
15. Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany.
Riechmann J; Strzelczyk A; Reese JP; Boor R; Stephani U; Langner C; Neubauer BA; Oberman B; Philippi H; Rochel M; Seeger J; Seipelt P; Oertel WH; Dodel R; Rosenow F; Hamer HM;
Epilepsia; 2015 Sep; 56(9):1388-97. PubMed ID: 26235849
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy.
Helmers SL; Duh MS; Guérin A; Sarda SP; Samuelson TM; Bunker MT; Olin BD; Jackson SD; Faught E
Eur J Paediatr Neurol; 2012 Sep; 16(5):449-58. PubMed ID: 22261080
[TBL] [Abstract][Full Text] [Related]
17. Health care cost associated with the use of enzyme-inducing and non-enzyme-active antiepileptic drugs in the UK: a long-term retrospective matched cohort study.
Borghs S; Thieffry S; Noack-Rink M; Dedeken P; Hong LS; Byram L; Logan J; Chan J; Kiri V
BMC Neurol; 2017 Mar; 17(1):59. PubMed ID: 28335764
[TBL] [Abstract][Full Text] [Related]
18. Cost of epilepsy care in a Nigerian tertiary hospital.
Sanya EO; Kolo PM; Adekeye A; Mustapha K; Ademiluyi BA; Ajayi K
Niger Postgrad Med J; 2013 Dec; 20(4):266-71. PubMed ID: 24633267
[TBL] [Abstract][Full Text] [Related]
19. [Survey of adults living with epilepsy in Hungary: health-related quality of life and costs].
Péntek M; Bereczki D; Gulácsi L; Mikudina B; Arányi Z; Juhos V; Baji P; Brodszky V
Ideggyogy Sz; 2013 Jul; 66(7-8):251-61. PubMed ID: 23971356
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of health-care utilization among adult patients with epilepsy in Germany.
Strzelczyk A; Nickolay T; Bauer S; Haag A; Knake S; Oertel WH; Reif PS; Rosenow F; Reese JP; Dodel R; Hamer HM
Epilepsy Behav; 2012 Apr; 23(4):451-7. PubMed ID: 22381385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
